Stein,K.FDA approves health claims labeling for food containing soy protein. J.Am.Dietetic Assoc . 2000Stein, K. (2000). FDA Approves Health Claim Labeling for Foods Containing Soy Protein, J. of the Am. Diet. Assoc., 100, 292.
Despite significant support for FDA's proposal to revoke the authorized claim on the role of soy protein in reducing coronary heart disease, some soy industry representatives remain hopeful they can still persuade FDA to hold off with the proposed change. 关键词: Soybean Proteins Claim HopefulnessSo...
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Rights and permissions Reprints and permissions About this article Cite this article Wang, H., Yang, L., Liu, M. et al. Protein post-translational modifications in...
Instead of using holo-structures as the input, we adopted a more challenging and realistic scenario during testing, where we assumed the holo protein conformation is not available and only use the protein conformations predicted by AlphaFold as our input. Holo conformations exhibit strong shape and ...
with many people having an intolerance to them. You want to make sure you read the label as well as the ingredients list carefully before making a final purchase. Check for claims like “only organic ingredients” or “no artificial ingredients or stabilizers or preservatives”. You also want ...
REGN10987: a patient-derived antibody that binds early variants of SARS-CoV-2 Spike32and that had an FDA EUA for use against these variants C143: an unmatured, patient-derived antibody that binds the SARS-CoV-2 Wuhan-Hu-1 Spike but was isolated before extensive in vivo somatic hypermutation...
FDA (2013) Claims that can be made for conventional foods and dietary supplements. http://www.fda.gov/Food/IngredientsPackagingLabeling/LabelingNutrition/ucm111447.htm. Accessed 8 Aug 2013 Fernández-Musoles R, Salom JB, Castelló-Ruiz M, Contreras MDM, Recio I, Manzanares P (2013a) Bioavaila...
Publisher’s noteSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. About this article Cite this article Jester, B.W., Zhao, H., Gewe, M.et al.Development of spirulina for the manufacture and oral delivery of protein therapeutics...
Publisher’s noteSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Related links C4 Therapeutics Announces FDA Clearance of Investigational New Drug Application for CFT8919, an Orally Bioavailable BiDACTM Degrader Targeting EGFR L858R for ...
Additional information Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Published in the topical collection Recent Trends in (Bio)Analytical Chemistry with guest editors Antje J. Baeumner and Günter Gauglitz....